Search for: "PFIZER" Results 1481 - 1500 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Dec 2015, 2:45 pm by Daniel Shaviro
Hillary Clinton has released, through her campaign website, a plan to address corporate inversions, such as the Pfizer-Allergan deal.In addition to limiting tax-effective inversions to deals in which the foreign "acquirer" is actually larger than the domestic "target" - thereby addressing "minnow swallows whale" deals that potentially can work (if not too extreme) under current law - the plan would also address the U.S. tax benefits that companies anticipate… [read post]
7 Dec 2015, 12:56 pm
**********PREVIOUSLY, ON NEVER TOO LATENever Too Late 74 [week ending on Sunday 29 November] –  Bob Marley copyright | Nintendo TPM triumphs in Italy | GIs and TMs in the EU | Prebalin again | YouTube will defend fair use | End-of-year reading |Stretchline Intellectual Properties Ltd v H&M Hennes & Mauritz UK Ltd | Goodbye from Jeremy, and thank you from us | Greekat on plain packaging | Rovi Guides Inc v Virgin Media Ltd & Others | IP… [read post]
2 Dec 2015, 2:13 pm by Robert B. Milligan and Amy Abeloff
., Intel, The Intellectual Property Owners Association (IPO), International Fragrance Association, North America, Johnson & Johnson, Medtronic, Micron, National Alliance for Jobs and Innovation (NAJI), National Association of Manufacturers (NAM), NIKE, Pfizer, Philips, The Procter & Gamble Company, SAS, Siemens Corporation, Software & Information Industry Association (SIIA), U.S. [read post]
1 Dec 2015, 6:36 am by Paul Caron
New York Times Deal Book: Pfizer’s Long War on Taxation, by Aaron Ross Sorkin: Long before Pfizer conceived of merging with Allergan in a $150 billion deal to rid itself of what its chief executive called an “an uncompetitive tax rate” in the United States, the company was deploying various... [read post]
30 Nov 2015, 3:34 am
**********PREVIOUSLY, ON NEVER TOO LATENever Too Late 73  [week ending on Sunday 22 November] –  Xmas present from Benelux PTO | Eponia never ending troubles |  Prof Dr Siegfried Broß v EPO | Protection of formats in the Netherlands | Eponia never ending proceedings | UK intensifies its Cracking Ideas programme | Anne Frank's Diary copyright | Transport for London and IP | CJEU in SBS Belgium v SABAM Case C-325/14 | COFIX,… [read post]
28 Nov 2015, 9:20 am by Paul Caron
New York Times Deal Book: Pfizer Didn’t Need an Inversion to Avoid Paying U.S. [read post]
25 Nov 2015, 6:47 am
 So this would not give Pfizer the same procedural flexibility. [read post]
25 Nov 2015, 3:17 am by Paul Caron
New York Times Deal Book: Why Pfizer’s Deal May Change the System of Taxing Multinationals, by Victor Fleischer (San Diego): Pfizer’s proposed merger with Allergan is a blockbuster deal in the pharmaceutical industry. [read post]
24 Nov 2015, 12:38 pm
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), and the rest of the First Circuit’s Neurontin trilogy, which took the top spot in our list of worst decisions of 2013. [read post]
24 Nov 2015, 6:51 am by Daniel Shaviro
But on the other hand, it's possible that some or all of their increased U.S. investment (if any) would come at the expense of investment by purely domestic companies that can't use Pfizer's cross-border tax planning techniques to lower their U.S. tax burdens.Pfizer, obviously, is doing what's good for Pfizer - be it the management (and/)or the shareholders. [read post]
24 Nov 2015, 2:00 am by Paul Caron
Loses Again Financial Times, Pfizer Set for Tax Windfall With Ireland Move Fortune, Why New Tax Inversion Rules Won't Stop Pfizer-Allergan Deal The Guardian, Pfizer's $155bn... [read post]
23 Nov 2015, 2:40 pm
 ****************** PREVIOUSLY, ON NEVER TOO LATE Never Too Late 72 [week ending on Sunday 15 November] –  Merck Sharp & Dohme v Ono Pharmaceutical | Warner-Lambert Co LLC v Sandoz GmbH, Sandoz Ltd and Lloyds Pharmcacy Ltd | Economics of internet trolls | UK IPO scammer scammed | Video conferencing at the EPO | Warner-Lambert v Pfizer in France | African Ministerial Conference in IP | Green claims and branding | CJEU… [read post]
23 Nov 2015, 7:31 am by Daniel Shaviro
Especially if one discounts for managerial incentives to high-ball this number, it clearly leaves a lot of value to be realized from the anticipated U.S. tax savings.The Times article says that Pfizer has $74 billion in offshore earnings. [read post]
18 Nov 2015, 10:01 am by Louthian Law Firm
In 2009, John Kopchinski, a former Pfizer sales representative who is also a West Point graduate, launched a qui tam suit which led to a government investigation into Pfizer’s illegal marketing of Bextra, a prescription painkiller that had caused deaths. [read post]
17 Nov 2015, 12:34 am
No need for Pregabalin(e) injunction, say the FrenchAfter Jeremy's post on the decision of Mr Justice Arnold in Warner-Lambert Co LLC v Sandoz GmbH, Sandoz Ltd and Lloyds Pharmcacy Ltd [2015] EWHC 3153 (Pat), in the Patents Court, England and Wales, to extend an interim injunction in an ongoing patent infringement dispute over pregabalin, here, Katfriend Grégoire Triet (Avocat au Barreau de Paris and a partner in the Paris-based practice… [read post]
16 Nov 2015, 12:35 pm by Paul Caron
Pfizer, which already holds roughly $140 billion overseas and... [read post]